Literature DB >> 18310078

Deletion of the protein kinase A/protein kinase G target SMTNL1 promotes an exercise-adapted phenotype in vascular smooth muscle.

Anne A Wooldridge1, Christopher N Fortner, Beata Lontay, Takayuki Akimoto, Ronald L Neppl, Carie Facemire, Michael B Datto, Ashley Kwon, Everett McCook, Ping Li, Shiliang Wang, Randy J Thresher, Sara E Miller, Jean-Claude Perriard, Timothy P Gavin, Robert C Hickner, Thomas M Coffman, Avril V Somlyo, Zhen Yan, Timothy A J Haystead.   

Abstract

In vivo protein kinases A and G (PKA and PKG) coordinately phosphorylate a broad range of substrates to mediate their various physiological effects. The functions of many of these substrates have yet to be defined genetically. Herein we show a role for smoothelin-like protein 1 (SMTNL1), a novel in vivo target of PKG/PKA, in mediating vascular adaptations to exercise. Aortas from smtnl1(-/-) mice exhibited strikingly enhanced vasorelaxation before exercise, similar in extent to that achieved after endurance training of wild-type littermates. Additionally, contractile responses to alpha-adrenergic agonists were greatly attenuated. Immunological studies showed SMTNL1 is expressed in smooth muscle and type 2a striated muscle fibers. Consistent with a role in adaptations to exercise, smtnl1(-/-) mice also exhibited increased type 2a fibers before training and better performance after forced endurance training compared smtnl1(+/+) mice. Furthermore, exercise was found to reduce expression of SMTNL1, particularly in female mice. In both muscle types, SMTNL1 is phosphorylated at Ser-301 in response to adrenergic signals. In vitro SMTNL1 suppresses myosin phosphatase activity through a substrate-directed effect, which is relieved by Ser-301 phosphorylation. Our findings suggest roles for SMTNL1 in cGMP/cAMP-mediated adaptations to exercise through mechanisms involving direct modulation of contractile activity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18310078      PMCID: PMC2431077          DOI: 10.1074/jbc.M708628200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  Phosphorylation of the regulatory light chains of myosin affects Ca2+ sensitivity of skeletal muscle contraction.

Authors:  Danuta Szczesna; Jiaju Zhao; Michelle Jones; Gang Zhi; James Stull; James D Potter
Journal:  J Appl Physiol (1985)       Date:  2002-04

2.  Purification and characterization of the mammalian myosin light chain phosphatase holoenzyme. The differential effects of the holoenzyme and its subunits on smooth muscle.

Authors:  A Shirazi; K Iizuka; P Fadden; C Mosse; A P Somlyo; A V Somlyo; T A Haystead
Journal:  J Biol Chem       Date:  1994-12-16       Impact factor: 5.157

3.  Effect of endurance training on beta-adrenergic system in three different skeletal muscles.

Authors:  G Plourde; S Rousseau-Migneron; A Nadeau
Journal:  J Appl Physiol (1985)       Date:  1993-04

4.  IRAG is essential for relaxation of receptor-triggered smooth muscle contraction by cGMP kinase.

Authors:  Angela Geiselhöringer; Matthias Werner; Katja Sigl; Petra Smital; René Wörner; Linda Acheo; Juliane Stieber; Pascal Weinmeister; Robert Feil; Susanne Feil; Jörg Wegener; Franz Hofmann; Jens Schlossmann
Journal:  EMBO J       Date:  2004-10-14       Impact factor: 11.598

5.  Loss of desmin leads to impaired voluntary wheel running and treadmill exercise performance.

Authors:  Kurt W Haubold; David L Allen; Yassemi Capetanaki; Leslie A Leinwand
Journal:  J Appl Physiol (1985)       Date:  2003-07-03

6.  Modulation of smooth muscle contractility by CHASM, a novel member of the smoothelin family of proteins.

Authors:  Meredith A Borman; Justin A MacDonald; Timothy A J Haystead
Journal:  FEBS Lett       Date:  2004-08-27       Impact factor: 4.124

7.  Smooth muscle phosphatase is regulated in vivo by exclusion of phosphorylation of threonine 696 of MYPT1 by phosphorylation of Serine 695 in response to cyclic nucleotides.

Authors:  Anne A Wooldridge; Justin A MacDonald; Ferenc Erdodi; Chaoyu Ma; Meredith A Borman; David J Hartshorne; Timothy A J Haystead
Journal:  J Biol Chem       Date:  2004-06-11       Impact factor: 5.157

8.  Skeletal muscle adaptation in response to voluntary running in Ca2+/calmodulin-dependent protein kinase IV-deficient mice.

Authors:  Takayuki Akimoto; Thomas J Ribar; R Sanders Williams; Zhen Yan
Journal:  Am J Physiol Cell Physiol       Date:  2004-06-30       Impact factor: 4.249

9.  Skeletal muscle adaptation to exercise training: AMP-activated protein kinase mediates muscle fiber type shift.

Authors:  Katja S C Röckl; Michael F Hirshman; Josef Brandauer; Nobuharu Fujii; Lee A Witters; Laurie J Goodyear
Journal:  Diabetes       Date:  2007-05-18       Impact factor: 9.461

10.  Chronic oral supplementation with sepiapterin prevents endothelial dysfunction and oxidative stress in small mesenteric arteries from diabetic (db/db) mice.

Authors:  Malarvannan Pannirselvam; Valerie Simon; Subodh Verma; Todd Anderson; Chris R Triggle
Journal:  Br J Pharmacol       Date:  2003-10       Impact factor: 8.739

View more
  15 in total

Review 1.  cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action.

Authors:  Sharron H Francis; Jennifer L Busch; Jackie D Corbin; David Sibley
Journal:  Pharmacol Rev       Date:  2010-09       Impact factor: 25.468

2.  Pregnancy and Smoothelin-like Protein 1 (SMTNL1) Deletion Promote the Switching of Skeletal Muscle to a Glycolytic Phenotype in Human and Mice.

Authors:  Beata Lontay; Khaldon Bodoor; Adrienn Sipos; Douglas H Weitzel; David Loiselle; Rachid Safi; Donghai Zheng; James Devente; Robert C Hickner; Donald P McDonnell; Thomas Ribar; Timothy A Haystead
Journal:  J Biol Chem       Date:  2015-06-05       Impact factor: 5.157

3.  Smoothelin-like 1 protein is a bifunctional regulator of the progesterone receptor during pregnancy.

Authors:  Khaldon Bodoor; Beata Lontay; Rachid Safi; Douglas H Weitzel; David Loiselle; Zhengzheng Wei; Szabolcs Lengyel; Donald P McDonnell; Timothy A Haystead
Journal:  J Biol Chem       Date:  2011-07-19       Impact factor: 5.157

4.  Smoothelin-like 1 protein regulates myosin phosphatase-targeting subunit 1 expression during sexual development and pregnancy.

Authors:  Beata Lontay; Khaldon Bodoor; Douglas H Weitzel; David Loiselle; Christopher Fortner; Szabolcs Lengyel; Donghai Zheng; James Devente; Robert Hickner; Timothy A J Haystead
Journal:  J Biol Chem       Date:  2010-07-15       Impact factor: 5.157

5.  Mapping and functional characterization of the murine smoothelin-like 1 promoter.

Authors:  Annegret Ulke-Lemée; Sara R Turner; Saad H Mughal; Meredith A Borman; Robert J Winkfein; Justin A MacDonald
Journal:  BMC Mol Biol       Date:  2011-02-27       Impact factor: 2.946

6.  Genome expression profiling and network analysis of nitrite therapy during chronic ischemia: possible mechanisms and interesting molecules.

Authors:  Christopher B Pattillo; Kai Fang; Sibile Pardue; Christopher G Kevil
Journal:  Nitric Oxide       Date:  2009-12-04       Impact factor: 4.427

7.  The role of the calponin homology domain of smoothelin-like 1 (SMTNL1) in myosin phosphatase inhibition and smooth muscle contraction.

Authors:  Meredith A Borman; Tiffany A Freed; Timothy A J Haystead; Justin A Macdonald
Journal:  Mol Cell Biochem       Date:  2009-02-14       Impact factor: 3.396

8.  Thromboxane A2-induced bi-directional regulation of cerebral arterial tone.

Authors:  Ronald L Neppl; Lubomir T Lubomirov; Ko Momotani; Gabriele Pfitzer; Masumi Eto; Avril V Somlyo
Journal:  J Biol Chem       Date:  2008-12-17       Impact factor: 5.157

9.  Microgenomic analysis in skeletal muscle: expression signatures of individual fast and slow myofibers.

Authors:  Francesco Chemello; Camilla Bean; Pasqua Cancellara; Paolo Laveder; Carlo Reggiani; Gerolamo Lanfranchi
Journal:  PLoS One       Date:  2011-02-22       Impact factor: 3.240

10.  Whole-Genome Sequencing Reveals Genetic Variation in the Asian House Rat.

Authors:  Huajing Teng; Yaohua Zhang; Chengmin Shi; Fengbiao Mao; Lingling Hou; Hongling Guo; Zhongsheng Sun; Jianxu Zhang
Journal:  G3 (Bethesda)       Date:  2016-07-07       Impact factor: 3.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.